CDIO Cardio Diagnostics Holdings, Inc.: Operatsion rentabellik

Cardio Diagnostics Holdings, Inc. (CDIO) brendining ramzi va logotipi

Cardio Diagnostics (CDIO) texnologik o'sish bosqichida bo'lib, makroiqtisodiy sikllardan mustaqil ravishda qon tahlili uchun AI xizmatlarini kengaytirmoqda. Genetik testlar barqaror B2B talabini shakllantirmoqda, bu esa kelajakdagi erkin pul oqimi uchun asos yaratmoqda. Biroq, joriy daromad klinikalarda tizimning joriy etilish sur'ati bilan cheklangan. Operatsion marja trayektoriyasi biznes samaradorligini namoyish etadi va ushbu ko'rsatkich -42649.80 darajasida mustahkamlandi.

CDIO - Cardio Diagnostics Holdings Inc. Operatsion foyda normasi 28.04.2023 - 19.11.2026 oraligʻida

CDIO (Cardio Diagnostics Holdings Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning asosiy tahlili:Cardio Diagnostics Holdings, CDIO
Cardio Diagnostics Holdings tayyor mahsulotlari

Operatsion marja foizlar va soliqlar to'lanishidan oldin asosiy operatsiyalardan olingan foyda ulushini o'lchaydi, bu esa xarajatlarni boshqarish samaradorligini va biznesning fundamental barqarorligini namoyish etadi. Ushbu operatsion rentabellik ko'rsatkichi tahlili investorlarga tibbiy daromadlar diversifikatsiyasi sharoitida Cardio Diagnostics (CDIO) kardiologik xavflarning oldini olish uchun o'zining genetik testlari va epigenetik tadqiqotlarini qanchalik muvaffaqiyatli monetizatsiya qilayotganini tushunish imkonini beradi.

Cardio Diagnostics (CDIO) raqobatchilari

Sotuvning operatsion marjasi A|DGX: Operatsion foyda normasi|Operatsion marja ILMN|EXAS (exactsciences.com) - Operatsion foyda normasi|Revvity Corp - Sotuvning operatsion marjasi|Operatsion foyda normasi BIO|Anbio Corp - Operatsion marja|Sotuvning operatsion rentabelligi Sterigenics|QDEL (QuidelOrtho Corp) - Sotuvning operatsion marjasi|OPK: Operatsion foyda koeffitsiyenti|CDNA (CareDx) - Operatsion marja|Maravai LifeSciences Holdings, Inc. (MRVI) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Fulgent Genetics, Inc. (FLGT)|LAB - Sotuvning operatsion rentabelligi|Operatsion marja CTKB (cytekbio.com)|Operatsion foyda normasi OSUR|XGN - Operatsion rentabellik|MDxHealth (MDXH) - Sotuvning operatsion marjasi|LUCD (Lucid Diagnostics) - Sotuvning operatsion marjasi|Prenetics Global Ltd (PRE) - Operatsion marja|Operatsion rentabellik Insight Molecular Diagnostics|TRIB: Operatsion foyda normasi|Operatsion rentabellik ProPhase (PRPH)|AIMD - Sotuvning operatsion rentabelligi|Operatsion rentabellik Co-Diagnostics, Inc. CODX|Operatsion marja Heart Test Laboratories HSCS|Biomerica Inc - Operatsion marja|Sotuvning operatsion rentabelligi onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Operatsion rentabellik|BJDX - Operatsion faoliyat rentabelligi|AWH (Aspira Women's Health, Inc.) - Operatsion marja|Accelerate Diagnostics, Inc (AXDX) - Operatsion faoliyat rentabelligi|Operatsion marja CNTG|ENZ - Sotuvning operatsion rentabelligi|Operatsion foyda normasi Fresh2 Group Ltd|Genetic Technologies (GENE) - Sotuvning operatsion rentabelligi|ME - Operatsion rentabellik|Operatsion faoliyat rentabelligi Psychemedics Corp PMD